Skip to search formSkip to main contentSkip to account menu

MF 934

Known as: MF-934 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

rufloxacin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1993
1993
Susceptibility of Salmonella typhi and Brucella melitensis to the new fluoroquinolone rufloxacin (MF 934).
The antimicrobial activity of the new fluoroquinolone rufloxacin (MF 934) was evaluated by a standardized agar dilution method… 
1993
1993
Comparative activity of the new fluoroquinolone rufloxacin (MF 934) against clinical isolates of gram-negative and gram-positive bacteria
The antibacterial activity of the new fluoroquinolone rufloxacin (MF 934) was evaluated against 1095 clinical isolates and… 
1992
1992
Ocular pharmacokinetics of rufloxacin a new fluoroquinolone antibiotic.
Ocular pharmacokinetics of rufloxacin (MF 934), a new monofluorinated quinolone derivative, has been investigated in rabbits. A… 
1991
1991
The inhibition of supercoiling activity of DNA gyrase from Micrococcus luteus caused by rufloxacin (MF 934) and MF 961.
1989
1989
Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
Rufloxacin (MF-934) is a new quinolone which shows in vitro antibacterial activity against E. coli, Salmonella, Klebsiella… 
1989
1989
Fluorimetric assay of rufloxacin in serum and in pharmaceutical formulations.
1988
1988
A new tricyclic fluoroquinolone, rufloxacin (MF-934), with interesting antibacterial and pharmacokinetic characteristics.
The kinetics of a new fluoroquinolone, rufloxacin (MF-934), have been studied in rats, dogs and monkeys. The drug is… 
1987
1987
Pharmacokinetic studies in rats with ofloxacin and MF-934, a new fluorinated quinolone.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)